Versant Capital Management, Inc - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 123 filers reported holding CYTOKINETICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q1 2021$10,000
-16.7%
419
-32.9%
0.00%
-20.0%
Q4 2020$12,000
-14.3%
624
-5.9%
0.01%
-16.7%
Q3 2020$14,000
-6.7%
6630.0%0.01%
-14.3%
Q2 2020$15,000
+275.0%
663
+90.0%
0.01%
+250.0%
Q1 2020$4,000
+33.3%
349
+3.6%
0.00%0.0%
Q4 2019$3,0000.0%3370.0%0.00%
+100.0%
Q3 2019$3,0000.0%3370.0%0.00%0.0%
Q2 2019$3,000337
+316.0%
0.00%
Q1 2019$0810.0%0.00%
Q4 2018$0810.0%0.00%
Q3 2018$081
+285.7%
0.00%
Q1 2018$0210.00%
Other shareholders
CYTOKINETICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$7,286,7218.83%
Saturn V Capital Management LP 406,225$13,251,0607.35%
Logos Global Management LP 1,650,000$53,823,0007.32%
Finepoint Capital LP 369,093$12,039,8144.16%
GREAT POINT PARTNERS LLC 600,000$19,572,0003.83%
Boxer Capital, LLC 2,100,000$68,5023.18%
PFM Health Sciences, LP 2,399,545$78,273,1583.04%
DAFNA Capital Management LLC 332,734$10,853,7832.97%
Integral Health Asset Management, LLC 650,000$21,203,0002.62%
Sofinnova Investments, Inc. 843,228$27,506,0971.80%
View complete list of CYTOKINETICS INC shareholders